How I treat autoimmune neutropenia in adults.

Autoimmune neutropenia in adults is typically chronic, with variable severity and a 50% detection rate of anti-neutrophil antibodies, often remaining asymptomatic.

• Why it matters: Understanding adult AiN is crucial because it differs from pediatric cases, often requiring tailored management strategies, yet evidence-based treatments are limited due to its rarity.
• What they did: The authors reviewed clinical features and treatment approaches in adult AiN, emphasizing observation, supportive care, and therapies targeting neutrophil production or immune destruction, including second-line cell-mediated and emerging treatments.
• The result: Most patients do well without active intervention, but second-line and novel therapies show promise, highlighting the need for collaborative efforts to refine treatment algorithms for this rare condition.